TBX1 and neoplasm: To date, therapeutic approaches for CAFs have focused on 3 main points: 1) the elimination of tumorigenic CAFs subsets; 2) the reversal of activated CAFs and tumor mesenchyme; and 3) the inhibition of CAFs activation signals.